"L'hôpital Renée Sabran-HCL se consacre à une activité diversifiée et uniquement programmée, que ce soit en médecine, en chirurgie ou en rééducation et réadaptation."

During the past decade, Hôpital Renée Sabran conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Renée Sabran" are "Congenital Hip Dysplasia" (1 trials), "Cystic Fibrosis Homozygous for Phe 508 Del CFTR" (1 trials), "Femoral Head Necrosis" (1 trials), "Femoral Neck Fracture" (1 trials) and "Glucose Intolerance or Newly Diagnosis Diabetes" (1 trials). Many other conditions were trialed in "Hôpital Renée Sabran" in a lesser frequency.

Most popular intervention types in "Hôpital Renée Sabran" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avantage Reload cup" (1 trials) and "Lumacaftor-Ivacaftor treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Renée Sabran" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Renée Sabran". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hôpital Renée Sabran, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Renée Sabran, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".